Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.

  • Authors : Pérez-Díez A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.; Liu X

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/blood ; Immunoglobulin M*/Immunoglobulin M*/Immunoglobulin M*/blood

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 17; Vol. 15, pp. 1352330. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1.

  • Authors : Tuttle DJ; Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.; Castanha PMS

Subjects: Complement Activation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use SARS-CoV-2 variants

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Apr 12; Vol. 229 (4), pp. 1147-1157.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Complement system is overactivated in patients with IgA nephropathy after COVID-19.

  • Authors : Guo WY; Renal Division, Department of Medicine, Beijing Anzhen Hospital, Capital Medical University, China.; Wang GQ

Subjects: Glomerulonephritis, IGA*/Glomerulonephritis, IGA*/Glomerulonephritis, IGA*/immunology ; Glomerulonephritis, IGA*/Glomerulonephritis, IGA*/Glomerulonephritis, IGA*/blood ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Jun; Vol. 263, pp. 110232. Date of Electronic Publication: 2024 May 01.Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.

  • Authors : Avraham M; Department of Cell and Developmental Biology, The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sinkovits G

Subjects: COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 23; Vol. 15, pp. 1337215. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions.

  • Authors : Bakos T; Nanomedicine Research and Education Center, Department of Translational Medicine, Semmelweis University, 1085 Budapest, Hungary.; Mészáros T

Subjects: Complement Inactivating Agents* ; COVID-19* ; Nanoparticles*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 22; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.

  • Authors : Ali YM; Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, Cambridge CB3 0ES, UK.; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.

Subjects: COVID-19* ; Respiratory Distress Syndrome*; Humans

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 680-690.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pathogenesis of Pulmonary Long COVID-19.

  • Authors : Borczuk AC; Northwell Health, Greenvale, New York. Electronic address: .

Subjects: COVID-19*; Humans ; Post-Acute COVID-19 Syndrome

  • Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Feb; Vol. 37 (2), pp. 100378. Date of Electronic Publication: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.

  • Authors : Meroni PL; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatologic Researches, Cusano Milanino, Milan, Italy. Electronic address: .; Croci S

Subjects: Complement Activation* ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Autoimmunity reviews [Autoimmun Rev] 2023 Jan; Vol. 22 (1), pp. 103232. Date of Electronic Publication: 2022 Nov 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Implications of Complement Imbalance in COVID-19: A Molecular Mechanistic Discussion on the Importance of Complement Balance.

  • Authors : Torabizadeh M; Golestan Hospital Clinical Research Development Unit, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Modaresi Asfeh H

Subjects: COVID-19*; Humans ; COVID-19 Drug Treatment

  • Source: Iranian journal of immunology : IJI [Iran J Immunol] 2023 Sep 01; Vol. 3 (20), pp. 247-261.Publisher: Iranian Society for Immunology & Allergy in association with Shīrāz Institute for Cancer Research Country of Publication: Iran NLM ID: 101282932

Record details

×
Academic Journal

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

  • Authors : Van Damme KFA; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Laboratory of Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium.

Subjects: Interleukin-6* ; COVID-19*; Humans

  • Source: Science translational medicine [Sci Transl Med] 2023 Aug 23; Vol. 15 (710), pp. eadi0252. Date of Electronic Publication: 2023 Aug 23.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  261 results for ""Complement Activation""